Concepedia

Central European Society for Anticancer Drug Research

CE

Statistics

Publications

21

Citations

581

Authors

1

Location

Vienna, Austria

Also known as CESAR-EWIV · Central European Society for Anticancer Drug Research - EWIV

Central European Society for Anticancer Drug Research is a nonprofit institution in Vienna, Austria known for oncology, medicine, and pharmacology.

HomepageROR

Top concepts

Publications

21

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)

Markus Joerger, Joachim von Pawel, Stefanie Kraff et al. · Annals of Oncology · 2016 · 85 citations

, , +5

Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice

Martin Wilhelm, Lothar Mueller, Michael Craig Miller et al. · Clinical Colorectal Cancer · 2016 · 65 citations

, , +8

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer

Lothar Bergmann, Luise Maute, Gerhard Heil et al. · European Journal of Cancer · 2014 · 62 citations

, , +8

Evaluation of a Pharmacology-Driven Dosing Algorithm of 3-Weekly Paclitaxel Using Therapeutic Drug Monitoring

Markus Joerger, Stefanie Kraff, Alwin D. R. Huitema et al. · Clinical Pharmacokinetics · 2012 · 56 citations

, , +9

Phase 2 HERALD study of patritumab (P) with erlotinib (E) in advanced NSCLC subjects (SBJs).

Joachim von Pawel, Jennifer Tseng, Mircea Dediu et al. · Journal of Clinical Oncology · 2014 · 21 citations

, , +15

1–5 of 21

Authors

1

  1. BM
    Berta Moritz

    Central European Society for Anticancer Drug Research, Austria

    30 publications · 855 citations

    9

    h-index

1–1 of 1